Physician profile
Don T Bui
NPI 1932313483
$22,994.44
in general payments reported to CMS, 2019-2025
43 companies · $4,024 in 2025
The $4,024 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $246 · 2021: $587 · 2022: $3,804 · 2023: $9,237 · 2024: $4,620 · 2025: $4,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,578 · Food and Beverage: $6,432 · Travel and Lodging: $1,871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,577.70 |
| Food and Beverage | $6,431.94 |
| Travel and Lodging | $1,870.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,940.18 | 2022-2024 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $1,683.95 | 2023-2025 | Aquabeam Robotic System |
| Abbvie INC. | $1,441.26 | 2019-2025 | Lupron Depot, Botox |
| Teleflex LLC | $1,085.94 | 2024-2025 | Barrigel, Urolift, Solesta |
| Sumitomo Pharma America, INC. | $644.45 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $508.36 | 2019-2025 | Xtandi, Myrbetriq |
| Merck Sharp & Dohme LLC | $439.31 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Urogen Pharma, INC. | $293.67 | 2020-2025 | Jelmyto |
| Janssen Biotech, INC. | $269.43 | 2021-2025 | Erleada |
| Boston Scientific Corporation | $233.14 | 2019-2023 | Ams 700 |
| Medtronic, INC. | $226.35 | 2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $216.42 | 2019-2025 | |
| Antares Pharma, INC. | $215.70 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Accord Healthcare, INC. | $210.42 | 2022-2025 | |
| Calyxo, INC. | $165.77 | 2024-2025 | Cvac Aspiration System |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bluewind Medical | $134.15 | 2024-2025 | Revi |
| Immunitybio, INC. | $118.72 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $106.13 | 2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Myovant Sciences INC. | $96.10 | 2021-2022 | |
| Pfizer INC. | $93.07 | 2019-2025 | |
| Urovant Sciences INC | $86.13 | 2022 | |
| Tolmar, INC. | $83.92 | 2024-2025 | Eligard |
| Novartis Pharmaceuticals Corporation | $64.66 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $42.24 | 2025 | Bard Urinary Drainage Bag |
| Axonics, INC. | $39.45 | 2023-2024 | Axonics |
| Femselect INC. | $37.31 | 2025 | Enplace |
| Aroa Biosurgery Incorporated | $37.12 | 2023 | |
| Allergan, INC. | $33.10 | 2020-2021 | |
| Biotissue Holdings INC. | $31.12 | 2022-2023 | |
| Bioprotect Medical, INC. | $30.56 | 2024 | Bioprotect Balloon Implant System |
| 180 Medical, INC. | $29.64 | 2022 | |
| Ferring Pharmaceuticals INC. | $29.33 | 2025 | Adstiladrin |
| Becton, Dickinson and Company | $28.45 | 2024 | Bard Urinary Drainage Bag |
| Dendreon Pharmaceuticals LLC | $27.44 | 2022 | |
| Endo USA, INC. | $26.50 | 2024 | Xiaflex |
| Palette Life Sciences, INC. | $26.47 | 2023 | |
| Coloplast Corp | $23.19 | 2023 | Coloplast Tfl Drive |
| Photocure INC | $22.90 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $22.69 | 2019 | |
| Halozyme INC | $18.77 | 2023 | |
| Mission Pharmacal Company | $16.08 | 2019 | |
| Agiliti Surgical, INC. | $14.85 | 2023 | Soltive, Sonablate, Trinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.